WallStSmart

Hinge Health, Inc. (HNGE)vsWaystar Holding Corp. Common Stock (WAY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Waystar Holding Corp. Common Stock generates 67% more annual revenue ($1.21B vs $720.06M). HNGE leads profitability with a 15.1% profit margin vs 11.2%. HNGE trades at a lower P/E of 11.5x. WAY earns a higher WallStSmart Score of 55/100 (C-).

HNGE

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 6.0Value: 6.7Quality: 5.0
Piotroski: 3/9Altman Z: -2.69

WAY

Buy

55

out of 100

Grade: C-

Growth: 8.0Profit: 6.0Value: 4.7Quality: 6.0
Piotroski: 3/9Altman Z: 1.55

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNGE3 strengths · Avg: 10.0/10
P/E RatioValuation
11.5x10/10

Attractively priced relative to earnings

Revenue GrowthGrowth
53.0%10/10

Revenue surging 53.0% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

WAY3 strengths · Avg: 8.7/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
24.4%8/10

Strong operational efficiency at 24.4%

Revenue GrowthGrowth
18.1%8/10

18.1% revenue growth

Areas to Watch

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
21.5x2/10

Trading at 21.5x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

WAY4 concerns · Avg: 3.5/10
P/E RatioValuation
36.7x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HNGE

The strongest argument for HNGE centers on P/E Ratio, Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.

Bull Case : WAY

The strongest argument for WAY centers on Price/Book, Operating Margin, Revenue Growth. Revenue growth of 18.1% demonstrates continued momentum.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Bear Case : WAY

The primary concerns for WAY are P/E Ratio, Altman Z-Score, Return on Equity.

Key Dynamics to Monitor

HNGE is growing revenue faster at 53.0% — sustainability is the question.

HNGE generates stronger free cash flow (100M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WAY scores higher overall (55/100 vs 52/100) and 18.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Waystar Holding Corp. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Waystar Holding Corp. The company is headquartered in Lehi, Utah.

Visit Website →

Want to dig deeper into these stocks?